Back | Next |
home / stock / imux / imux message board
Subject | By | Source | When |
---|---|---|---|
$IMUX Get in now!!!! | BoilerRoom | investorshub | 10/12/2022 8:02:01 PM |
$IMUX huge run after hours today! | BoilerRoom | investorshub | 10/12/2022 7:59:08 PM |
$IMUX in at $9.55 | BoilerRoom | investorshub | 10/12/2022 7:55:55 PM |
znewcar1: $IMUX 51% v27,7M c9.41 f30,56M H9.64 Haft9.87 | znewcar1 | investorshangout | 10/11/2022 8:20:11 PM |
Going gangbusters into closing bell ! | crudeoil24 | investorshub | 10/11/2022 7:59:10 PM |
I sold and it up | Pt3 | investorshub | 10/11/2022 1:55:19 PM |
Not cool....lol | masterofdisaster | investorshub | 10/11/2022 1:52:15 PM |
Cool | Pt3 | investorshub | 10/11/2022 11:51:29 AM |
Bought some cheap $5 puts late day yesterday | masterofdisaster | investorshub | 10/11/2022 11:31:54 AM |
Yup puts everywhere | Pt3 | investorshub | 10/10/2022 9:29:02 PM |
Everything feels like puts anymore | masterofdisaster | investorshub | 10/10/2022 9:26:42 PM |
znewcar1: $IMUX 56% v46,7M c6.20 f30,5M H6.23 ML2.96 gap >5 held and pushed to HOD @ EOD | znewcar1 | investorshangout | 10/10/2022 9:12:18 PM |
Puts on good news lol | Pt3 | investorshub | 10/10/2022 7:46:48 PM |
Puts | masterofdisaster | investorshub | 10/10/2022 3:27:29 PM |
Have to find some way to increase the | tzan24 | investorshub | 10/10/2022 2:14:42 PM |
$IMUX: However, it appears that their SHARES-SELLING business | Invest-in-America | investorshub | 10/10/2022 2:11:23 PM |
None of their clinical studies were successful, this | tzan24 | investorshub | 10/10/2022 2:09:34 PM |
$IMUX: So, now they're in the SHARES-SELLING busine | Invest-in-America | investorshub | 10/10/2022 2:03:40 PM |
Just chased | Pt3 | investorshub | 10/10/2022 1:17:43 PM |
Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement | subslover | investorshub | 10/10/2022 12:29:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Immunic Appoints Jason Tardio as Chief Operating Officer and President PR Newswire – Former Novartis and Biogen Executive Brings Extensive Multiple Sclerosis Drug Commercialization Experience to Immunic – – Werner Gladdines, Current Vice President,...
--News Direct-- Immunic Inc CEO Daniel Vitt joined Steve Darling from Proactive to discuss the ongoing challenges and recent developments in treating multiple sclerosis (MS). This interview took place in conjunction with World MS Day, a day dedicated to raising global awareness about this...
Immunic to Participate in Industry and Scientific Conferences in June PR Newswire NEW YORK , May 28, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule thera...